{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:01:25Z","timestamp":1780531285715,"version":"3.54.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-026-27443-9","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:46:44Z","timestamp":1776772004000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatitis B in China: the analysis of mortality and burden of disease trends from 2008 to 2021"],"prefix":"10.1186","volume":"26","author":[{"given":"Haoyu","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mufei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changlin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianzhu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"issue":"9","key":"27443_CR1","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","volume":"7","author":"regional Global","year":"2022","unstructured":"Global regional, national burden of hepatitis B. 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. lancet Gastroenterol Hepatol. 2022;7(9):796\u2013829.","journal-title":"lancet Gastroenterol Hepatol"},{"issue":"8","key":"27443_CR2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","volume":"20","author":"YC Hsu","year":"2023","unstructured":"Hsu YC, Huang DQ, Nguyen MH. Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nat reviews Gastroenterol Hepatol. 2023;20(8):524\u201337.","journal-title":"Nat reviews Gastroenterol Hepatol"},{"key":"27443_CR3","doi-asserted-by":"publisher","first-page":"18035","DOI":"10.1038\/nrdp.2018.35","volume":"4","author":"MF Yuen","year":"2018","unstructured":"Yuen MF, Chen DS, Dusheiko GM, Janssen HLA, Lau DTY, Locarnini SA, et al. Hepatitis B virus infection. Nat reviews Disease primers. 2018;4:18035.","journal-title":"Nat reviews Disease primers"},{"issue":"2","key":"27443_CR4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S2468-1253(19)30342-5","volume":"5","author":"SK Sarin","year":"2020","unstructured":"Sarin SK, Kumar M, Eslam M, George J, Al Mahtab M, Akbar SMF, et al. Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission. lancet Gastroenterol Hepatol. 2020;5(2):167\u2013228.","journal-title":"lancet Gastroenterol Hepatol"},{"issue":"1","key":"27443_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41392-025-02197-9","volume":"10","author":"Q Xiao","year":"2025","unstructured":"Xiao Q, Liu Y, Li T, Wang C, He S, Zhai L, et al. Viral oncogenesis in cancer: from mechanisms to therapeutics. Signal Transduct Target therapy. 2025;10(1):151.","journal-title":"Signal Transduct Target therapy"},{"issue":"2","key":"27443_CR6","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1016\/S2214-109X(21)00547-7","volume":"10","author":"C Wang","year":"2022","unstructured":"Wang C, Cui F. Expanded screening for chronic hepatitis B virus infection in China. Lancet Global health. 2022;10(2):e171\u20132.","journal-title":"Lancet Global health"},{"issue":"2","key":"27443_CR7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/HEP.0000000000001373","volume":"33","author":"RH Wang","year":"2025","unstructured":"Wang RH, Hu JJ, Li Z, Han X. [Analysis of epidemiological characteristics of hepatitis B mortality status from 2006 to 2021 among Chinese residents]. Zhonghua gan zang bing za zhi\u2009=\u2009Zhonghua ganzangbing zazhi\u2009=\u2009Chinese. J Hepatol. 2025;33(2):128\u201334.","journal-title":"J Hepatol"},{"issue":"30","key":"27443_CR8","doi-asserted-by":"publisher","first-page":"727","DOI":"10.46234\/ccdcw2024.164","volume":"6","author":"L Wang","year":"2024","unstructured":"Wang L, Liu N, Miao N, Zhang G, Wang F, Wang H. Trends and Age-Period-Cohort Effect on Acute Hepatitis B Incidence - China, 2005\u20132021. China CDC Wkly. 2024;6(30):727\u201333.","journal-title":"China CDC Wkly"},{"issue":"1","key":"27443_CR9","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s40249-025-01345-1","volume":"14","author":"YR Xiao","year":"2025","unstructured":"Xiao YR, Ren X, Zhang MD, Zhu H, Wang X, Sun WS, et al. Analysis of regional characteristics in mortality trends of three chronic infectious diseases among the elderly in China, 2004\u20132021. Infect Dis Poverty. 2025;14(1):70.","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"27443_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.2471\/BLT.15.153148","volume":"94","author":"S Liu","year":"2016","unstructured":"Liu S, Wu X, Lopez AD, Wang L, Cai Y, Page A, et al. An integrated national mortality surveillance system for death registration and mortality surveillance. China Bull World Health Organ. 2016;94(1):46\u201357.","journal-title":"China Bull World Health Organ"},{"issue":"1","key":"27443_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12963-021-00249-0","volume":"19","author":"MJ Sheu","year":"2021","unstructured":"Sheu MJ, Liang FW, Lin CY, Lu TH. Changes in liver-related mortality by etiology and sequelae: underlying versus multiple causes of death. Popul health metrics. 2021;19(1):22.","journal-title":"Popul health metrics"},{"issue":"1","key":"27443_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3138\/canlivj-2020-0026","volume":"4","author":"J Li","year":"2021","unstructured":"Li J, Casey JL, Greenwald ZR, Yasseen Iii AS, Dickie M, Feld JJ, et al. The 9th Canadian Symposium on Hepatitis C Virus: Advances in HCV research and treatment towards elimination. Can liver J. 2021;4(1):59\u201371.","journal-title":"Can liver J"},{"issue":"3","key":"27443_CR13","first-page":"236","volume":"12","author":"X Wang","year":"2024","unstructured":"Wang X, Liu H, Qi J, Wang L, Yin P, Liu F, et al. Trends in Mortality of Cirrhosis in China: An Analysis of the China Death Surveillance Database from 2008 to 2020. J Clin translational Hepatol. 2024;12(3):236\u201344.","journal-title":"J Clin translational Hepatol"},{"key":"27443_CR14","doi-asserted-by":"publisher","first-page":"06042","DOI":"10.7189\/jogh.13.06042","volume":"13","author":"G Cao","year":"2023","unstructured":"Cao G, Liu J, Liu M, Liang W. Effects of the COVID-19 pandemic on life expectancy at birth at the global, regional, and national levels: A joinpoint time-series analysis. J global health. 2023;13:06042.","journal-title":"J global health"},{"key":"27443_CR15","doi-asserted-by":"publisher","unstructured":"Li HZ, Du LB. [Application of Joinpoint regression model in cancer epidemiological time trend analysis]. Zhonghua Yu Fang Yi Xue Za Zhi. 2020;54(8):908\u201312. https:\/\/doi.org\/10.3760\/cma.j.cn112150-20200616-00889.","DOI":"10.3760\/cma.j.cn112150-20200616-00889"},{"issue":"1","key":"27443_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40880-018-0282-3","volume":"38","author":"M Ilic","year":"2018","unstructured":"Ilic M, Ilic I. Cancer mortality in Serbia, 1991\u20132015: an age-period-cohort and joinpoint regression analysis. Cancer Commun (London England). 2018;38(1):10.","journal-title":"Cancer Commun (London England)"},{"issue":"3","key":"27443_CR17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","volume":"19","author":"HJ Kim","year":"2000","unstructured":"Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335\u201351.","journal-title":"Stat Med"},{"key":"27443_CR18","doi-asserted-by":"crossref","unstructured":"Fiaz MA, Munir A, Raza H, Rehman RY, Amjad M, Durrani MK. Epidemiology, Prevalence and Preventive Guidelines of Hepatitis B Virus Infection. J Med Health Sci Rev. 2025;2(1):404\u201339.","DOI":"10.62019\/nbsjvt58"},{"issue":"5","key":"27443_CR19","doi-asserted-by":"publisher","first-page":"a021410","DOI":"10.1101\/cshperspect.a021410","volume":"5","author":"JH MacLachlan","year":"2015","unstructured":"MacLachlan JH, Cowie BC. Hepatitis B virus epidemiology. Cold Spring Harbor Perspect Med. 2015;5(5):a021410.","journal-title":"Cold Spring Harbor Perspect Med"},{"issue":"1","key":"27443_CR20","doi-asserted-by":"publisher","first-page":"12075","DOI":"10.1038\/s41598-022-16360-7","volume":"12","author":"E Hamilton","year":"2022","unstructured":"Hamilton E, Yang L, Mentzer AJ, Guo Y, Chen Y, Lv J, et al. Conventional and genetic risk factors for chronic Hepatitis B virus infection in a community-based study of 0.5 million Chinese adults. Sci Rep. 2022;12(1):12075.","journal-title":"Sci Rep"},{"issue":"8","key":"27443_CR21","first-page":"921","volume":"5","author":"UH Iloeje","year":"2007","unstructured":"Iloeje UH, Yang HI, Jen CL, Su J, Wang LY, You SL, et al. Risk and predictors of mortality associated with chronic hepatitis B infection. Clinical gastroenterology and hepatology: the official clinical practice. J Am Gastroenterological Association. 2007;5(8):921\u201331.","journal-title":"J Am Gastroenterological Association"},{"key":"27443_CR22","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/978-981-16-3615-8_9","volume-title":"Hepatitis B Virus and Liver Disease","author":"H-C Yang","year":"2021","unstructured":"Yang H-C, Su T-H. Viral and Host Factors Affecting Disease Progression of Hepatitis B Virus Infection. In: Kao J-H, editor. Hepatitis B Virus and Liver Disease. Singapore: Springer Singapore; 2021. pp. 205\u201330."},{"key":"27443_CR23","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.2147\/CLEP.S389853","volume":"14","author":"C Zhang","year":"2022","unstructured":"Zhang C, Liu Y, Zhao H, Wang G. Global Patterns and Trends in Total Burden of Hepatitis B from 1990 to 2019 and Predictions to 2030. Clin Epidemiol. 2022;14:1519\u201333.","journal-title":"Clin Epidemiol"},{"issue":"5","key":"27443_CR24","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3201\/eid2305.161477","volume":"23","author":"F Cui","year":"2017","unstructured":"Cui F, Shen L, Li L, Wang H, Wang F, Bi S, et al. Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China. Emerg Infect Dis. 2017;23(5):765\u201372.","journal-title":"Emerg Infect Dis"},{"key":"27443_CR25","doi-asserted-by":"crossref","unstructured":"Chen S, Mao W, Guo L, Zhang J, Tang S. Combating hepatitis B and C by 2030: achievements, gaps, and options for actions in China. BMJ Glob Health. 2020;5(6):e002306.","DOI":"10.1136\/bmjgh-2020-002306"},{"key":"27443_CR26","doi-asserted-by":"publisher","first-page":"100249","DOI":"10.1016\/j.lanwpc.2021.100249","volume":"16","author":"M Li","year":"2021","unstructured":"Li M, Zhao L, Zhou J, Sun Y, Wu X, Ou X, et al. Changing clinical care cascade of patients with chronic hepatitis B in Beijing, China. Lancet Reg health Western Pac. 2021;16:100249.","journal-title":"Lancet Reg health Western Pac"},{"key":"27443_CR27","doi-asserted-by":"crossref","unstructured":"Yuan J, Lu ZK, Xiong X, Jiang B. Lowering drug prices and enhancing pharmaceutical affordability: an analysis of the national volume-based procurement (NVBP) effect in China. BMJ Glob Health. 2021;6(9):e005519.","DOI":"10.1136\/bmjgh-2021-005519"},{"issue":"1","key":"27443_CR28","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1186\/s12879-019-4428-y","volume":"19","author":"H Wang","year":"2019","unstructured":"Wang H, Men P, Xiao Y, Gao P, Lv M, Yuan Q, et al. Hepatitis B infection in the general population of China: a systematic review and meta-analysis. BMC Infect Dis. 2019;19(1):811.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"27443_CR29","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.jhep.2021.04.035","volume":"75","author":"DY Zeng","year":"2021","unstructured":"Zeng DY, Li JM, Lin S, Dong X, You J, Xing QQ, et al. Global burden of acute viral hepatitis and its association with socioeconomic development status, 1990\u20132019. J Hepatol. 2021;75(3):547\u201356.","journal-title":"J Hepatol"},{"issue":"1","key":"27443_CR30","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1186\/s12889-025-22452-6","volume":"25","author":"K Fang","year":"2025","unstructured":"Fang K, Cheng N, Nie C, Song W, Zhao Y, Pan J, et al. Spatial and temporal distribution patterns and factors influencing hepatitis B in China: a geo-epidemiological study. BMC Public Health. 2025;25(1):1276.","journal-title":"BMC Public Health"},{"issue":"6","key":"27443_CR31","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/jvh.13816","volume":"30","author":"EM Hamilton","year":"2023","unstructured":"Hamilton EM, Rassam W, Yan Y, Singh A, Ng SYA, Zhang J, et al. Correlates of chronic hepatitis B virus infection in the general adult population of China: Systematic review and meta-analysis. J Viral Hepatitis. 2023;30(6):470\u201388.","journal-title":"J Viral Hepatitis"},{"issue":"1","key":"27443_CR32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12939-020-1139-3","volume":"19","author":"Y Wang","year":"2020","unstructured":"Wang Y, Li Y, Qin S, Kong Y, Yu X, Guo K, et al. The disequilibrium in the distribution of the primary health workforce among eight economic regions and between rural and urban areas in China. Int J Equity Health. 2020;19(1):28.","journal-title":"Int J Equity Health"},{"issue":"2","key":"27443_CR33","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/grow.12382","volume":"51","author":"X Luo","year":"2020","unstructured":"Luo X, Zhang Z, Xu X, Li C, Zhang L. Birth without raising: Impact of labor migration on the medical benefits for migrant children in China. Growth Change. 2020;51(2):809\u201332.","journal-title":"Growth Change"},{"key":"27443_CR34","doi-asserted-by":"crossref","unstructured":"Bai X, Chen L, Liu X, Tong Y, Wang L, Zhou M, et al. Adult Hepatitis B Virus Vaccination Coverage in China from 2011 to 2021: A Systematic Review. Vaccines. 2022;10(6):900.","DOI":"10.3390\/vaccines10060900"},{"issue":"6","key":"27443_CR35","doi-asserted-by":"publisher","first-page":"e2219170","DOI":"10.1001\/jamanetworkopen.2022.19170","volume":"5","author":"KN Ly","year":"2022","unstructured":"Ly KN, Yin S, Spradling PR. Regional Differences in Mortality Rates and Characteristics of Decedents With Hepatitis B Listed as a Cause of Death, United States, 2000\u20132019. JAMA Netw open. 2022;5(6):e2219170.","journal-title":"JAMA Netw open"},{"key":"27443_CR36","doi-asserted-by":"publisher","first-page":"1068078","DOI":"10.3389\/fpubh.2022.1068078","volume":"10","author":"AC Wang","year":"2022","unstructured":"Wang AC, Geng JH, Wang CW, Wu DW, Chen SC. Sex difference in the associations among risk factors with hepatitis B and C infections in a large Taiwanese population study. Front public health. 2022;10:1068078.","journal-title":"Front public health"},{"issue":"2","key":"27443_CR37","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00281-018-0727-4","volume":"41","author":"N Buettner","year":"2019","unstructured":"Buettner N, Thimme R. Sexual dimorphism in hepatitis B and C and hepatocellular carcinoma. Semin Immunopathol. 2019;41(2):203\u201311.","journal-title":"Semin Immunopathol"},{"key":"27443_CR38","doi-asserted-by":"publisher","first-page":"e13828","DOI":"10.7717\/peerj.13828","volume":"10","author":"M Liu","year":"2022","unstructured":"Liu M, Li L, Zhao J, Ungvari GS, Ng CH, Duan Z, et al. Gender differences in demographic and clinical characteristics in patients with HBV-related liver diseases in China. PeerJ. 2022;10:e13828.","journal-title":"PeerJ"},{"key":"27443_CR39","first-page":"476","volume":"122","author":"T Yue","year":"2022","unstructured":"Yue T, Zhang Q, Cai T, Xu M, Zhu H, Pourkarim MR, et al. Trends in the disease burden of HBV and HCV infection in China from 1990\u20132019. Int J Infect diseases: IJID : official publication Int Soc Infect Dis. 2022;122:476\u201385.","journal-title":"Int J Infect diseases: IJID : official publication Int Soc Infect Dis"},{"key":"27443_CR40","doi-asserted-by":"publisher","first-page":"101193","DOI":"10.1016\/j.lanwpc.2024.101193","volume":"51","author":"Z Hui","year":"2024","unstructured":"Hui Z, Yu W, Fuzhen W, Liping S, Guomin Z, Jianhua L, et al. New progress in HBV control and the cascade of health care for people living with HBV in China: evidence from the fourth national serological survey, 2020. Lancet Reg health Western Pac. 2024;51:101193.","journal-title":"Lancet Reg health Western Pac"},{"issue":"8","key":"27443_CR41","doi-asserted-by":"publisher","first-page":"e028248","DOI":"10.1136\/bmjopen-2018-028248","volume":"9","author":"M Zhang","year":"2019","unstructured":"Zhang M, Wu R, Xu H, Uhanova J, Gish R, Wen X, et al. Changing incidence of reported viral hepatitis in China from 2004 to 2016: an observational study. BMJ open. 2019;9(8):e028248.","journal-title":"BMJ open"},{"issue":"12","key":"27443_CR42","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1002\/jmv.24890","volume":"89","author":"M Osawa","year":"2017","unstructured":"Osawa M, Akuta N, Suzuki F, Fujiyama S, Kawamura Y, Sezaki H, et al. Prognosis and predictors of hepatocellular carcinoma in elderly patients infected with hepatitis B virus. J Med Virol. 2017;89(12):2144\u20138.","journal-title":"J Med Virol"},{"key":"27443_CR43","doi-asserted-by":"publisher","first-page":"1654356","DOI":"10.3389\/fpubh.2025.1654356","volume":"13","author":"L Gao","year":"2025","unstructured":"Gao L, Ren Y, Hu S, Zhang Y, Bai H, Li J, et al. Global, regional, and national total burden related to hepatitis B and attributable risk factors in adults aged 65 years and older from 1990 to 2021 and projection to 2030. Front public health. 2025;13:1654356.","journal-title":"Front public health"},{"issue":"9","key":"27443_CR44","doi-asserted-by":"publisher","first-page":"e701","DOI":"10.1016\/S2468-2667(23)00149-4","volume":"8","author":"B Hepatitis","year":"2023","unstructured":"Hepatitis B. in Europe: an update from the Global Burden of Disease Study 2019. Lancet Public health. 2023;8(9):e701\u201316.","journal-title":"Lancet Public health"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-27443-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-27443-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-27443-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T23:06:43Z","timestamp":1780528003000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-27443-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["27443"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-27443-9","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"31 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1791"}}